C-reactive protein as a regulator of autoimmunity and inflammation

Arthritis and Rheumatism

Volumn 48, Issue 6, 2003, Pages 1475-1477

  Du Clos, Terry W ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; C REACTIVE PROTEIN; FC RECEPTOR;

AUTOIMMUNITY; EDITORIAL; HUMAN; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNITY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; MICE; MODELS, ANIMAL;

EID: 0038653248     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11025     Document Type: Editorial

References (26)

1. Pepys MB, Lanham JG, De Beer FC. C-reactive protein in SLE. Clin Rheum Dis 1982;8:91-103.
2. Du Clos TW, Mold C. The role of C-reactive protein in resolution of bacterial infection. Curr Opin Infect Dis 2001;14:289-93.
3. Kaplan MH, Volanakis JE. Interactions of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 1974;112:2135-47.
4. Kindmark C-O. Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria. Clin Exp Immunol 1971;8:941-8.
5. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is FcγRII. J Exp Med 1999;190:585-90.
6. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW. C-reactive protein binds to FcγRI in transfected COS cells. J Immunol 1995;155:2185-93.
7. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from human monocytes by C-reactive protein. Cytokine 1992;4:361-8.
8. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells. J Exp Med 1993;178:1629-36.
9. Mold C, Rodriguez W, Rodic-Polic B, Du Clos TW. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR. J Immunol 2002;169:7019-25.
10. Gershov D, Kim S, Brot N, Elkon KB. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 2000;192:1353-63.
11. Familian A, Zwart B, Huisman HG, Rensink I, Roem D, Hordijk PL, et al. Chromatin-independent binding of serum amyloid P component to apoptotic cells. J Immunol 2001;167:647-54.
12. Burlingame RW, Volzer MA, Harris J, Du Clos TW. The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice. J Immunol 1996;156:4783-8.
13. 1 mice expressing a human C-reactive protein transgene. Arthritis Rheum 2003;48:1602-1611.
14. 1 mice treated with C-reactive protein. Clin Immunol Immunopathol 1994;70:22-7.
15. Robey FA, Jones KD, Tanaka T, Liu T-Y. Binding of C-reactive protein to chromatin and nucleosome core particles: a possible physiological role of C-reactive protein. J Biol Chem 1984;259:7311-6.
16. Du Clos TW. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J Immunol 1989;143:2553-9.
17. Jewell WS, Marnell LL, Rokeach LA, Du Clos TW. C-reactive protein binding to the Sm-D protein of snRNPs: identification of a short polypeptide binding region. Mol Immunol 1993;30:701-8.
18. Bickerstaff MCM, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999;5:694-7.
19. Nakayama S, Du Clos TW, Gewurz H, Mold C. Inhibition of antibody responses to phosphocholine by C-reactive protein. J Immunol 1984;132:1336-40.
20. Heuertz RM, Dongyuan X, Samols D, Webster RO. Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am J Physiol 1994;266:L649-54.
21. Xia D, Samols D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci U S A 1997;94:2575-80.
22. Sutterwala FS, Noel GJ, Salgame P, Mosser DM. Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I. J Exp Med 1998;188:217-22.
23. Sutterwala FS, Noel GJ, Clynes R, Mosser DM. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 1997;11:1977-85.
24. Szalai AJ, Nataf S, Hu X-Z, Barnum SR. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J Immunol 2002;168:5792-7.
25. Du Clos TW, Rodriguez W, Kataranovski M, Rodic-Polic B, Mold C. Enhanced survival of NZBXNZW F1 female mice receiving a single injection of human CRP [abstract]. FASEB J 2003;17:C38.
26. Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998;279:1052-4.